Skip to main content
Clinical Trials/NCT04200534
NCT04200534
Active, not recruiting
Early Phase 1

Improving the Quality of Smoking Cessation and Shared Decision Making for Lung Cancer Screening: A Cluster Randomized Trial

M.D. Anderson Cancer Center3 sites in 1 country358 target enrollmentJuly 31, 2020

Overview

Phase
Early Phase 1
Intervention
Questionnaire Administration
Conditions
Smoking
Sponsor
M.D. Anderson Cancer Center
Enrollment
358
Locations
3
Primary Endpoint
Smoking abstinence Questionnairre
Status
Active, not recruiting
Last Updated
8 months ago

Overview

Brief Summary

This trial studies how well a centralized care strategy works in improving the quality of smoking cessation and shared decision making among patients who smoke and are considering lung cancer screening. The centralized care strategy is a model where smokers eligible for lung cancer screening are referred to a dedicated tobacco treatment program where they receive both the shared decision-making and initiate smoking cessation counseling prior to their visit with a primary care provider. Utilizing the centralized care model may work better in helping people quit smoking and make informed decisions about lung cancer screening compared to usual care.

Detailed Description

PRIMARY OBJECTIVE: I. Test the effectiveness of usual care (primary care providers with training in guideline-based smoking cessation and shared decision making) versus (vs.) centralized care (smoking cessation and shared decision making delivered remotely by trained counselors) on smoking abstinence and the quality of patients' decisions about lung cancer screening. SECONDARY OBJECTIVES: I. Evaluate the reach, acceptability, feasibility, and fidelity of the two smoking cessation and shared decision-making implementation models in meeting the requirements from Centers for Medicare \& Medicaid Services (CMS) for the lung cancer screening patient counseling and shared decision making visit. II. Conduct budget impact and cost-effectiveness analyses of the two implementation models for the smoking cessation and shared decision making to inform adoption of the intervention beyond the current study. OUTLINE: Participants are randomized to 1 of 2 groups. GROUP I (CENTRALIZED CARE): Participants receive counseling over the phone to help them quit smoking and learn about lung cancer screening over 15-20 minutes for 6-8 sessions over 8 weeks. Participants may also receive nicotine patches. GROUP II (USUAL CARE): Participants receive counseling on lung cancer screening and smoking cessation from primary care providers at health care visit. After completion of study, participants are followed up at 1, 8, and 12 weeks.

Registry
clinicaltrials.gov
Start Date
July 31, 2020
End Date
February 28, 2027
Last Updated
8 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • PATIENTS: Primary care patients
  • PATIENTS: Upcoming primary care office visit
  • PATIENTS: Current smoker
  • PATIENTS: 30 plus (+) pack-year smoking history
  • PATIENTS: English-speaking
  • PROVIDERS: Primary health care providers
  • PROVIDERS: Provide care to adults

Exclusion Criteria

  • PATIENTS: History of lung cancer by self-report

Arms & Interventions

Group II (usual care)

Participants receive counseling on lung cancer screening and smoking cessation from primary care providers at health care visit.

Intervention: Questionnaire Administration

Group I (centralized care strategy)

Participants receive counseling over the phone to help them quit smoking and learn about lung cancer screening over 15-20 minutes for 6-8 sessions over 8 weeks. Participants may also receive nicotine patches.

Intervention: Questionnaire Administration

Group II (usual care)

Participants receive counseling on lung cancer screening and smoking cessation from primary care providers at health care visit.

Intervention: Quality-of-Life Assessment

Group I (centralized care strategy)

Participants receive counseling over the phone to help them quit smoking and learn about lung cancer screening over 15-20 minutes for 6-8 sessions over 8 weeks. Participants may also receive nicotine patches.

Intervention: Nicotine Patch

Group I (centralized care strategy)

Participants receive counseling over the phone to help them quit smoking and learn about lung cancer screening over 15-20 minutes for 6-8 sessions over 8 weeks. Participants may also receive nicotine patches.

Intervention: Quality-of-Life Assessment

Group I (centralized care strategy)

Participants receive counseling over the phone to help them quit smoking and learn about lung cancer screening over 15-20 minutes for 6-8 sessions over 8 weeks. Participants may also receive nicotine patches.

Intervention: Tobacco Cessation Counseling

Group II (usual care)

Participants receive counseling on lung cancer screening and smoking cessation from primary care providers at health care visit.

Intervention: Best Practice

Outcomes

Primary Outcomes

Smoking abstinence Questionnairre

Time Frame: Up to 12 weeks

Participants achieving the primary abstinence endpoint at 12 weeks (higher 7-day point prevalence abstinence rates)

Lung Cancer Screening 12 items version

Time Frame: Up to 12 weeks

Knowledge of lung cancer screening and benefits of smoking cessation

Secondary Outcomes

  • Acceptability, appropriateness, and feasibility of the intervention measure (Weiner et al).(Up to 12 weeks)
  • Fidelity checklist (11 items)(Up to 12 weeks)
  • Number of patients who received smoking cessation counseling and shared decision making over the number of patients consented to participate in the study(Up to 12 weeks)
  • EuroQoL-5 dimensions(Up to 12 weeks)
  • Costs of implementing any smoking cessation plus shared decision making intervention(Up to 12 weeks)

Study Sites (3)

Loading locations...

Similar Trials